Spleen cancer in dogs has no single known cause, but a combination of genetic predisposition, breed, body size, and possibly hormonal factors all play a role. The most common malignant tumor of the dog spleen is hemangiosarcoma, a fast-growing cancer that arises from the cells lining blood vessels. There is currently no evidence that any specific lifestyle change, diet, or environmental exposure definitively triggers it.
Hemangiosarcoma Is the Primary Concern
When veterinarians talk about spleen cancer in dogs, they’re almost always talking about hemangiosarcoma. A systematic review published in the Journal of the American Veterinary Medical Association examined over 1,150 dogs with ruptured splenic masses and found that 73% had a malignant tumor. Of those malignancies, 87% were hemangiosarcoma. That means roughly two out of three dogs presenting with a bleeding splenic mass will have this specific cancer.
Other malignant tumors can develop in the spleen, including lymphoma and histiocytic sarcoma, but they are far less common. Histiocytic sarcoma has a known familial pattern in Bernese Mountain Dogs specifically. The remaining roughly 27% of splenic masses turn out to be benign, often blood-filled growths called hematomas that can look identical to cancer on imaging.
Genetics and Breed Are the Strongest Risk Factors
Large-breed dogs are disproportionately affected by splenic tumors. German Shepherds and Golden Retrievers carry the highest risk for hemangiosarcoma, with Labrador Retrievers close behind. The pattern is strong enough that researchers consider genetic inheritance a major driver of the disease, though no single mutation has been pinpointed as the definitive cause.
The fact that certain breeds cluster so heavily suggests inherited traits in how blood vessel cells grow, repair themselves, or respond to damage over time. This isn’t a simple one-gene problem. It likely involves multiple genetic pathways interacting with each other, which is part of why it has been so difficult to develop screening tests or preventive strategies.
Hormonal Influences in Female Dogs
A 2013 study tracking Golden Retrievers found a surprising connection between spaying timing and hemangiosarcoma risk in females. Female dogs spayed at 12 months or older were diagnosed with hemangiosarcoma at a rate of 7.4%, compared to just 1.6% in intact females and 1.8% in those spayed before 12 months. That’s more than a fourfold increase for late-spayed females.
Even more striking, the average age of onset for late-spayed females was only 3.2 years, compared to 6.4 years for intact females and 7.6 years for early-spayed females. In male dogs, neutering status made no measurable difference in hemangiosarcoma rates. This hormonal connection remains poorly understood, and the data comes from a single breed, so it may not apply equally to all dogs. Still, it points to sex hormones playing some role in how this cancer develops, at least in genetically predisposed females.
Environmental Exposures Under Investigation
Researchers have not yet confirmed a link between environmental chemicals and spleen cancer in dogs. However, the Morris Animal Foundation is actively investigating whether persistent organic pollutants contribute to hemangiosarcoma risk. Their study is measuring blood levels of pesticides like DDT, industrial compounds such as PCBs, and flame retardants in Golden Retrievers enrolled in the Golden Retriever Lifetime Study.
The University of Minnesota’s veterinary oncology program has stated directly that there is no current evidence hemangiosarcoma can be prevented by eliminating exposure to certain toys, environmental factors, or special diets. That doesn’t rule out environmental contributors entirely, but it means dog owners shouldn’t blame themselves for something in their home or yard. The disease appears to be driven primarily from within, by the dog’s own genetic makeup.
Why Spleen Cancer Is So Hard to Catch Early
One of the cruelest features of splenic hemangiosarcoma is that it produces few or no symptoms until it reaches a dangerous stage. A tumor can grow quietly inside the spleen for weeks or months. When signs do appear, they tend to be vague: mild tiredness, reluctance to exercise, or a slight drop in appetite. These are easy to chalk up to aging or a bad day.
The first obvious sign is often a crisis. When a splenic tumor ruptures, it bleeds into the abdomen, causing sudden collapse, rapid breathing, pale gums, and severe weakness. Some dogs die suddenly without any prior warning. This is why the cancer is frequently diagnosed in the emergency room rather than during a routine checkup. By the time it ruptures, it has often already spread to the liver, lungs, or heart.
What Happens After Diagnosis
The standard treatment for a splenic mass is surgical removal of the spleen. Dogs can live normally without a spleen, so the surgery itself is generally well tolerated. The critical question is what the biopsy reveals afterward.
For confirmed hemangiosarcoma, the prognosis is sobering. A study of 208 dogs found that the median survival time after spleen removal alone was 1.6 months. Adding chemotherapy showed some benefit in the first four months following surgery, reducing the risk of death during that window, but when researchers looked at overall survival across the full follow-up period, there was no statistically significant difference between dogs who received chemotherapy and those who did not. The cancer spreads aggressively, and most dogs eventually succumb to metastatic disease regardless of treatment.
These numbers are averages, and individual dogs can outperform them. But they underscore why researchers are so focused on finding ways to detect this cancer earlier or identify at-risk dogs before tumors develop.
Age and Body Size as Contributing Factors
Splenic hemangiosarcoma is overwhelmingly a disease of middle-aged to older dogs, with most cases appearing after age 6. Larger dogs face higher risk than smaller breeds, and this holds true even outside the highest-risk breeds. The reasons likely involve a combination of factors: larger dogs have more cells undergoing division (creating more opportunities for cancerous mutations), longer blood vessels with more lining cells where hemangiosarcoma originates, and breed-specific genetic vulnerabilities that travel alongside genes for large body size.
Small-breed dogs can develop splenic tumors, but their masses are more likely to be benign. When a Yorkie or Chihuahua has a splenic mass, the odds tilt more favorably than they do for a German Shepherd with the same finding on ultrasound.